Martin A. Lehr is CEO at Context Therapeutics Inc. (CNTX). They have made 5 open-market trades across 1 company since 2021, most recently 2025-06-09.
CIK 0001861989
5 open-market purchases totalling $230K since 2021, never a sale. Across 5 scored buys the stock is down 17.9% at ninety days, and 18.0 points behind the S&P over the same stretch.
5 scored purchases · one row per filing · discretionary only
| Ticker | Shares | Value |
|---|---|---|
| CNTX | 920,190 | $224K |
Shares reported on the most recent Form 4, priced at the 2025-06-10 close.
| 7d | 30d | 90d | |
|---|---|---|---|
| Accuracy | 0% | 20% | 20% |
| Avg Move | -9.2% | -19.5% | -17.9% |
| Alpha | -10.1% | -18.9% | -18.0% |
| Scored | 5 | 5 | 5 |
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| CNTX | BUY | 2025-06-09 | 2025-06-10 | $0.70 | $70K | -21.8% | -6.9% | +14.1% |
| CNTX | BUY | 2023-02-21 | 2023-02-21 | $0.84 | $5K | -6.2% | -24.7% | -20.4% |
| CNTX | BUY | 2023-02-13 | 2023-02-13 | $0.87 | $5K | -9.4% | -18.6% | -42.0% |
| CNTX | BUY | 2023-02-06 | 2023-02-06 | $0.97 | $5K | -13.7% | -20.1% | -38.3% |
| CNTX | BUY | 2023-01-30 | 2023-01-30 | $0.70 | $5K | -27.0% | -37.6% | -53.3% |
| CNTX | BUY | 2023-01-23 | 2023-01-23 | $0.72 | $5K | +39.4% | +15.5% | -17.7% |
| CNTX | BUY | 2023-01-17 | 2023-01-18 | $0.74 | $5K | +0.4% | +21.7% | -2.9% |
| CNTX | BUY | 2022-12-16 | 2022-12-19 | $0.74 | $15K | -3.9% | +0.5% | -2.7% |
| CNTX | BUY | 2022-08-19 | 2022-08-22 | $1.85 | $24K | -6.9% | -36.0% | -37.4% |
| CNTX | BUY | 2021-12-16 | 2021-12-20 | $3.22 | $42K | -7.0% | -27.6% | -26.6% |
| CNTX | BUY | 2021-10-22 | 2021-12-17 | $5.00 | $50K | -6.4% | -27.6% | -36.7% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.